PRICE T ROWE ASSOCIATES INC /MD/

Position in STRO — Sutro Biopharma, Inc.

CIK 80255 BALTIMORE, MD

Position in STRO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$451,419

+$430,669 QoQ

Shares Held

13,597

+268.6% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#57

of 97 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. STRO ranks #210 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$451,419	13,597	-63.1%	Shares	Sole	2026-08-14
2025-03-31	$20,750	36,893	+22.2%	Shares	Sole	2025-05-14
2024-12-31	$55,566	30,199	+15.0%	Shares	Defined	2025-02-14
2024-09-30	$90,842	26,255	0.0%	Shares	Defined	2024-11-14
2024-06-30	$76,927	26,255	+45.6%	Shares	Defined	2024-08-14
2024-03-31	$101,852	18,027	+24.8%	Shares	Defined	2024-05-15
2023-12-31	$61,986	14,449	+10.2%	Shares	Defined	2024-02-16
2023-09-30	$45,505	13,114	+13.6%	Shares	Defined	2023-11-14
2023-06-30	$53,698	11,548	-46.0%	Shares	Defined	2023-08-14
2021-03-31	$487,041	21,399	+2.1%	Shares	Sole	2021-05-17
2020-12-31	$455,215	20,968	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.